8.89
+0.11(+1.25%)
Currency In USD
Address
Avinguda de la Generalitat, 152
Barcelona, 08174
Spain
Phone
34 93 571 02 21
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
23833
First IPO Date
June 02, 2011
| Name | Title | Pay | Year Born |
| Mr. Jose Ignacio Abia Buenache | Chief Executive Officer & Director | 0 | 1968 |
| Mr. Víctor Grifols Deu | Executive Director | 5.12M | 1977 |
| Mr. David Ian Bell | Chief Corporate Affairs & Legal Officer | 0 | 1954 |
| Mr. Camille Alpi | Chief Human Resources & Talent Officer | 0 | 1982 |
| Daniel Segarra | Head of Investor Relations & Sustainability and Vice President | 0 | N/A |
| Mr. Enrique de la Torre | Chief Compliance Officer | 0 | 1972 |
| Mr. Vicente Blanquer Torre | Chief Quality Officer | 0 | 1961 |
| Ms. Montse Ribas | Chief Communications and Reputation Officer | 0 | 1968 |
| Mr. Rahul Srinivasan | Chief Financial Officer | 0 | 1977 |
| Mr. Lluis Pons Gomez | Senior Vice President of Strategy & Chief Operating Officer Office | 0 | 1984 |
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.